KRYS
Krystal Biotech Inc
350.90$
+5.1%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | +62.7% | |
| – | +1,050.0% | +513.0% | +430.5% | +147.5% | +49.6% | +46.4% | +23.5% | +34.1% | -2.4% | |
| – | +645.5% | +222.0% | +56.4% | +164.1% | +368.2% | +116.9% | +20.2% | +23.0% | +11.0% | |
| – | +8,672.5% | -77.4% | +64.9% | +205.5% | +321.3% | +93.6% | – | – | – | |
| – | – | +2.6% | -428.6% | – | +121.1% | +37.0% | -1,447.6% | – | – | |
| – | +1,300.0% | +963.8% | +186.4% | +132.0% | +360.4% | -22.5% | -77.7% | -64.1% | +182.0% | |
| – | +1,300.0% | +4,815.7% | -51.9% | +125.1% | +1,928.2% | -49.7% | – | -297.8% | -64.3% | |
| – | – | – | – | – | – | – | – | – | – | |
| – | +3,418.4% | +49.3% | +45.6% | +9.8% | +201.3% | – | – | – | – | |
| – | +24.7% | – | – | – | – | – | – | – | – | |
| – | +1,493.4% | +42.6% | +45.6% | +9.8% | +194.6% | -89.8% | +473.6% | -86.7% | -67.8% | |
| – | +2,378.8% | +13.4% | +55.0% | -3.7% | -9.6% | -345.8% | – | -106.9% | – | |
| – | – | – | – | – | – | – | – | – | +58.5% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.